Press

News from the Lung Institute

Press Contact: Communications Team
Phone: (877) 867-4551
Communications@lunginstitute.com
the-lung-institute-a-leader-in-stem-cell-therapy-for-treatment-of-lung-disease-wins-tampa-small-business-excellence-award

The Lung Institute, a leader in Stem Cell Therapy for Treatment of Lung Disease, Wins Tampa Small Business Excellence Award

The Lung Institute has garnered a Tampa Bay area business award. In August, the Tampa Small Business Excellence group named us the 2017 Tampa Small Business Excellence Award winner in the Pulmonologist category. This shows recognition of our informative and consistent efforts to help people with lung diseases gain awareness of the treatments we offer…

Read More >

Other Press Articles

the-lung-institute-donation-helps-employees-son-run-in-aau-national-track-meet
Lung Institute Applauds Texas Medical Freedom Act
Lung Institute Addresses Link Between COPD and Depression in Honor of World Health Day

* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. The Lung Institute is firmly in accordance with the conditions set by the FDA for exemption status and conducts itself in full accordance with current guidelines. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and stem cell procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.